Ignite Creation Date:
2025-12-24 @ 12:45 PM
Ignite Modification Date:
2026-02-13 @ 5:48 AM
Study NCT ID:
NCT02510261
Status:
COMPLETED
Last Update Posted:
2023-12-06
First Post:
2015-07-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Participants Who Have Already Been Treated With ALN-TTR02 (Patisiran)
Sponsor:
Alnylam Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ALN-TTR02-006
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None